Medline Industries LP

PitchBook发布的《2026年医疗保健展望报告》指出，2026年全球医疗保健行业将加速复苏，人工智能（AI）技术应用、政策改革与并购活动升温成为核心驱动力，生物科技、医疗技术、健康科技等细分领域呈现差异化增长机遇，行业整体迎来数十年难遇的投资窗口期。生物科技与制药领域迎来结构性机遇。生物制药风险投资活动已于2025年第二季度触底回升，2026年将持续改善，利率下调与政策不确定性消除将提振投机性投资。AI技术正革命性重塑药物研发，AI驱动的临床试验一期成功率达80%-90%，远超行业平均的40%-65%，有望将整体研发成功率从7.9%提升至17.7%，同时缩短研发周期、降低成本。早期资产因前期资金不足，将成为回报潜力最大的细分领域，预期投资回报率将超过2012-2014年周期19.5%的内部收益率。GLP-1领域竞争白热化，超120个在研资产引发大型药企并购争夺战，特朗普政府的医保定价协议将扩大市场覆盖，同时推动行业向口服制剂、多靶点激动剂等差异化方向发展。医疗服务行业面临重构与机遇并存。后疫情时代医疗利用率稳步回升，婴儿潮一代进入高医疗需求阶段，支撑行业增长。但医保补贴到期、 Medicaid资格收紧将加剧商业保险成本压力，2026年家庭医保保费预计上涨9%，推动行业迎来重大监管改革。AI自动化将大规模落地，智能 scribing、临床决策支持等工具将减少医生行政负担与倦怠，推动医疗机构精简行政人员。多专科诊所、门诊手术中心（ASCs）与第三方管理机构成为投资焦点，两者的整合协同将加速，消化内科、骨科等领域的场景融合将成为趋势。医疗技术（Medtech）行业复苏势头明确。全球医疗技术风险投资将创下三年新高，诊断、手术、心血管领域成为投资热点，AI赋能成为核心竞争力。大型企业剥离非核心资产后，将积极并购AI驱动型技术公司以应对竞争，行业并购活动将提速。神经刺激、智能植入物、增强现实手术等前沿技术进入商业化初期，肾神经消融技术的医保覆盖为同类技术提供了可借鉴路径。IPO市场选择性开放，Medline Industries的上市将测试市场对传统医疗技术企业的接受度，而Heartflow、Caris等企业的上市则彰显创新型企业的资本吸引力。健康科技（Healthtech）与医疗IT领域整合加剧。健康科技风险投资自2023年触底后缓慢回升，AI语音记录、支付完整性管理成为融资热门赛道，Oura等可穿戴设备企业获大额融资。行业呈现“强强联合”趋势，私募股权支持的医疗IT企业将频繁并购风投背景的健康科技公司，以弥补AI能力短板。支付方与提供商的AI应用存在差距，提供商端渗透率近乎支付方的两倍，2026年支付方将加速布局支付完整性等AI解决方案。IPO市场逐步重启，Hinge Health、Omada Health等规模化护理管理平台引领上市浪潮，Quantum Health、Cohere Health等企业有望跟进。政策与监管层面变动频繁。美国医保改革将提速，Medicare风险调整体系重构、突破性设备报销流程简化等政策有望落地。《平价医疗法案》（ACA）相关改革呼声高涨，包括调整年龄费率区间、放宽基本健康福利要求、强化健康激励措施等。关税环境趋于稳定，但美国对中国医疗组件的关税及232条款调查仍构成潜在风险。2026年医疗保健行业将呈现“AI重塑、政策驱动、并购整合”三大特征。投资者应聚焦AI赋能的药物研发、医疗技术创新、高效医疗服务模式与健康科技平台型企业，同时关注政策变动与估值合理性带来的风险。免责声明：我们尊重知识产权、数据隐私，只做内容的收集、整理及分享，报告内容来源于网络,报告版权归原撰写发布机构所有，通过公开合法渠道获得，如涉及侵权，请及时联系我们删除，如对报告内容存疑，请与撰写、发布机构联系返回搜狐，查看更多

This recall involves updating instructions for using certain devices and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without following the updated instructions. Affected Products This recall contains Medline medical convenience kits containing the Flexicare BritePro Solo, including convenience kits labeled as: Device Name Kit Number UDI-DI Lots NEWBORN RESUSCITATION KIT ACC010381C 10193489922127 (EA), 40193489922128 (CS) 21LDA450, 21KDA979, 21JDB271, 21LDA608 DRAWER 5 - POSITION 3 ACC010532 10193489902358 (EA), 40193489902359 (CS) 21FDA234 DRAWER #4C ADULT ACC010671 10195327351090 (EA), 40195327351091 (CS) 23EDC536 DRAWER #2 ACC010728 UDI/DI 10195327506544 (EA), 40195327506545 (CS) 24EDC276, 23KDC368, 23KDB032 ADULT INTUBATION TRAY ACC010369B 10193489777512 (EA) 40193489777513(CA) 21DDA738, 21CDA614, 21BDA717 ADULT ICU INTUBATION TRAY ACC010379A 10193489777529 (EA) 40193489777520(CA) 21BDB738, 21BDB493 INTUBATION TRAY ACC010392 10193489218053 (EA) 40193489218054(CA) 24JDA206, 21HDB930, 21HDA284, 21EDB901, 21EDB869, 21EDB805 INTUBATION KIT ACC010467A 10193489834550 (EA) 40193489834551(CA) 21EDA887 ADULT AIRWAY TRAY ACC010469 10193489414677 (EA) 40193489414678(CA) 22BDA430, 21KDA741, 21CDA522, 21BDA753 TRAY 2 INTUBATION DRAWER ACC010480 10193489499933 (EA) 40193489499934(CA) 21HDA876, 21FDB951, 21FDB019, 21EDA065, 21CDB872, 21BDB094 TRAY 2 INTUBATION DRAWER ACC010480A 10195327009366 (EA) 40195327009367(CA) 21JDB163 ADULT INTUBATION ACC010540 10193489977547 (EA) 40193489977548(CA) 21IDC276 DIFFICULT AIRWAY TRAY #1 ACC010593A 10195327168995 (EA) 40195327168996(CA) 22EDB290 DIFFICULT AIRWAY TRAY #1 ACC010593B 10195327195472 (EA) 40195327195473(CA) 22FDB947 INTUBATION TRAY DYNDA1847A 10193489481259 (EA) 40193489481250(CA) 21FBG208, 21CBL507 INTUBATION TRAY (ADULT) DYNJAA245A 10193489804584 (EA) 40193489804585(CA) 21LBV006, 21IBV349, 21HBT154, 21DBI703, 21CBN261 What to Do Place the over-labels provided by Medline Industries on affected kits to indicate that the affected component should be removed and discarded prior to using the kit. On July 25, 2025, Medline Industries, LP sent all affected customers an immediate action required medical device recall recommending the following actions: Immediately check your stock for the affected item number(s) and the affected lot number(s) listed within the recall portal. Quarantine all affected product. Please complete the recall response form. Please list the quantity of affected product in inventory on the form. Even if there is no affected product in inventory, please complete and submit the form. Upon receipt of the submitted response form, over-labels will be provided to be placed on affected inventory, with instructions for staff to remove and discard the affected component prior to using the kit. These labels will be provided via FedEx overnight, if applicable. Alert any person or company to whom this kit may have been resold or transferred of this recall communication. Please include customers’ quantities on the response form. Check this web page for updates. The FDA is currently reviewing information about this potentially high-risk device issue and will keep the public informed as significant new information becomes available. Reason for Updated Use Instructions Medline Industries, LP is updating the use instructions for their medical convenience kits containing the previously recalled component Flexicare BritePro Solo due to the light not illuminating as intended. If the light malfunctions, it may prevent effective illumination of the patient airway. The use of affected product may cause serious adverse health consequences, including delay in treatment or requiring intubation using a different device and possibly death. As of August 8, 2005, Medline Industries has not reported any serious injuries or deaths associated with this issue. Device Use This recall is for Medline medical convenience kits containing the Flexicare BritePro Solo. The BritePro Solo devices are intended for direct vision laryngoscopy to obtain an illuminated view of the vocal cords and the glottis by inserting the laryngoscope blade into the oral cavity to manipulate the tongue or epiglottis. Contact Information Customers in the U.S. with adverse reactions, quality problems, or questions about this recall should contact the Medline Recall Department at 866-359-1704 or recalls@medline.com . Additional FDA Resources: Additional Company Resources: Company provided information on a recall, is posted here by the FDA as a public service. Unique Device Identifier (UDI) The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly. How do I report a problem? Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Content current as of: 11/21/2025 Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product LRO - Sterile Medline Convenience Kits: MAJOR PACK L-F, Model Number: DYNJ0382730O LB BASIC CUSTOM PACK, Model Number: DYNJ61038B OJH – Sterile Medline Convenience Kits: EXTREMITY PACK, Model Number: DYNJ45701B What to Do Do not use affected kits. Respond to the firm with all requested information. On August 8, 2025, Medline Industries reached out to the five affected customers asking for confirmation on the number of affected units and to hold those kits. On August 22, 2025, Medline Industries, LP sent all five affected customers an Urgent Medical Device Recall notice providing formal documentation of the recall. Medline will provide disposition as soon as possible. Reason for Recall Medline Industries, LP is recalling certain sterile Medline Convenience Kits due to mislabeling as sterile without completing the sterilization process. These convenience kits were manufactured at a Medline site and shipped directly to distribution centers instead of to the sterilization site first. These kits, meant to be sterile, were shipped non-sterilized to distribution centers, where the affected lots were released to a small number of customers. The use of affected product may cause serious adverse health consequences, including bloodstream infection, fevers, sepsis and death. There have been no reported injuries or deaths related to this issue. Device Use DYNJ0382730O (Major Pack L-F): This pack is a convenience custom pack that supports general surgery procedures in adult patients. Procedures may include abdominal procedures such as bowel resections and appendectomies. DYNJ45701B (Extremity Pack): This pack is a convenience custom pack that supports orthopedic surgery procedures in adult patients. Procedures may include knee replacement, ankle ORIF and foot surgeries. DYNJ61038B (LB Basic Custom Pack): This pack is a convenience custom pack that would support general surgery procedures in pediatric patients, such as hernia repairs. The contents of all three of these packs include products that establish the sterile field, which supports patient safety and infection prevention. Contact Information Customers in the U.S. with questions about this recall should contact Medline Industries at 1-866-359-1704. Additional FDA Resources: Unique Device Identifier (UDI) The unique device identifier (UDI) helps identify individual medical devices sold in the United States from manufacturing through distribution to patient use. The UDI allows for more accurate reporting, reviewing, and analyzing of adverse event reports so that devices can be identified, and problems potentially corrected more quickly. How do I report a problem? Health care professionals and consumers may report adverse reactions or quality problems they experienced using these devices to MedWatch: The FDA Safety Information and Adverse Event Reporting Program. Content current as of: 11/20/2025 Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.